Comparison of supramesenteric aortic cross-clamping with supraceliac aortic cross-clamping for aortic reconstruction

Sungho Lim, Pegge M. Halandras, Naveed U. Saqib, Y. Avery Ching, Edward Villella, Taeyoung Park, Hyunju Son, Jae S. Cho

Research output: Contribution to journalArticlepeer-review

7 Citations (Scopus)


Objective Supraceliac aortic cross-clamping (SCXC) is routinely used during open aortic reconstruction (OAR) of pararenal aortic disease when suprarenal control is not feasible. On occasion, however, aortic control may be obtained at the supramesenteric level by supramesenteric cross-clamping (SMXC) between the superior mesenteric artery and the celiac axis. The purpose of this study was to compare outcomes between patients who had SMXC vs SCXC during OAR for both aneurysmal and occlusive diseases. Methods A retrospective chart review identified 69 patients who underwent elective OAR requiring SMXC (n = 18) or SCXC (n = 51). All patients with thoracoabdominal aneurysms and those who had inframesenteric (suprarenal and infrarenal) aortic control were excluded. Propensity score-based matching was performed to adjust for confounding factors in a 1:1 ratio to compare outcomes. Late survival was estimated by Kaplan-Meier methods. Results Propensity score-based matching was performed at a 1:1 ratio; 18 SMXC cases were matched with 18 SCXC cases. The average age was 66.7 years, and men constituted 72%. Baseline characteristics were matched, except for the incidence of peripheral vascular occlusive disease (72.2% in the SMXC group vs 33.3% in the SCXC group; P =.04). A majority (80.6%) of patients underwent OAR for aneurysmal disease (72.2% in the SMXC group, 88.9% in the SCXC group). Intraoperatively, there were no differences in operative times (325 minutes for SMXC vs 298 minutes for SCXC; P = .48), but the SMXC group had a longer renal ischemia time (40 minutes vs 28 minutes; P =.03). There were no significant differences in intraoperative blood loss (2.4 L vs 1.6 L; P =.2) or blood product transfusion requirements (packed red blood cells, 2.2 units vs 1.6 units [P =.5]; Cell Saver, 1.3 L vs 0.7 L [P =.09]). Overall complication rates did not differ significantly (27.8% for SMXC vs 44.4% for SCXC; P =.24). Thirty-day mortality rates did not differ between the two groups (0% for SMXC vs 5.6% for SCXC; P = 1). Conclusions In this study, there were no differences in early morbidity or mortality between SMXC and SCXC during aortic reconstruction. SMXC, however, can be performed safely and effectively in properly selected patients. A larger, multicenter prospective study would help elucidate the potential benefits.

Original languageEnglish
Pages (from-to)941-947
Number of pages7
JournalJournal of Vascular Surgery
Issue number4
Publication statusPublished - 2016 Oct 1

Bibliographical note

Publisher Copyright:
© 2016 Society for Vascular Surgery

All Science Journal Classification (ASJC) codes

  • Surgery
  • Cardiology and Cardiovascular Medicine


Dive into the research topics of 'Comparison of supramesenteric aortic cross-clamping with supraceliac aortic cross-clamping for aortic reconstruction'. Together they form a unique fingerprint.

Cite this